Neuronetics Inc (STIM) Live Share Price, Invest From India

Neuronetics Inc Stock Performance

as on November 7, 2025 at 12:37 am IST

Day's Low
Day's High
$2.45
Day's Price Range
$2.76
$2.73
10.26%
Downside
1.10%
Upside
52 Week's Low
52 Week's High
$0.52
52-Week Price Range
$5.92
$2.73
80.95%
Downside
116.85%
Upside

Neuronetics Inc share price movements today

Previous Close: $2.74
Open: $2.71
Volume: 2.3M
Day's Low - High: $2.45 - $2.76
52 Week Low - High: $0.52 - $5.92

Neuronetics Inc Historical Returns

1 Month Return: -3.18 %
3 Month Return: -35.45 %
1 Year Return: + 130.25 %
3 Year Return: -23.46 %
5 Year Return: -60 %

Neuronetics Inc Stock Fundamentals & Key Indicators

Check Neuronetics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$196.6M

EPS (TTM)

-0.61

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.79

Industry PE ratio

-0.8126129032258065

PEG Ratio

EBITDA

-35.0M

Revenue (TTM)

111.1M

Profit Margin

-43.92%

Return On Equity TTM

-190.79%

Neuronetics Inc Stock Valuation

Track how Neuronetics Inc P/E has moved over time to understand its valuation trends.

Neuronetics Inc in the last 5 years

Overview
Trends

Lowest (-14.24x)

June 30, 2021

Industry (-0.81x)

November 6, 2025

Today (-0.79x)

November 6, 2025

Highest (-0.76x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.79x

Neuronetics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neuronetics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neuronetics Inc	BUY	$196.6M	-60%	-0.79	-43.92%
Boston Scientific Corp.	BUY	$146.5B	177.03%	52.86	14.43%
Stryker Corporation	BUY	$138.7B	67.57%	47.15	12.07%
Abbott Laboratories	BUY	$218.8B	8.84%	15.55	31.88%
Edwards Lifesciences Corp.	BUY	$48.6B	6.16%	36.17	23.25%

See all

Stock Returns calculator for Neuronetics Inc Stock including INR - Dollar returns

The Neuronetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Neuronetics Inc investment value today

Current value as on today

₹2,34,447

Returns

₹1,34,447

(+134.45%)

Returns from Neuronetics Inc Stock

₹1,29,412 (+129.41%)

Dollar Returns*

₹5,036 (+5.04%)

Analyst Recommendation on Neuronetics Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Neuronetics Inc. Average target price of $6.5

Neuronetics Inc Share Price Target

Get share price movements and forecasts by analysts on Neuronetics Inc.

What analysts predicted

58%UPSIDE

Target Price

$6.5

Current Price

$2.73

Analyzed by

10 Analysts

Target

$6.50

Neuronetics Inc target price $6.5, a slight upside of 58% compared to current price of $2.73. According to 10 analysts rating.

Neuronetics Inc Stock’s Investor Sentiment and Interest

Search interest for Neuronetics Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: October 8, 2025 to November 7, 2025

Change:33% versus previous 30 day period

Neuronetics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	15	17	17	20	17	16	18	22	31	38
Gross Profit	11	12	11	15	12	12	14	14	15	17
Operating Income	-9	-7	-8	-4	-6	-8	-7	-11	-11	-8
EBITDA	-8	-3	-7	-3	-5	-7	-11	-10	-9	-7
Interest Expense	1	1	1	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-4	-9	-5	-7	-9	-13	-12	-12	-9
Income Tax Expense	0	4	1	-7	0	-	-	-	-	-
Net Income	-11	-4	-9	-5	-7	-9	-13	-12	-12	-10
Net Profit Margin	-71.64%	-27.83%	-52.51%	-26.47%	-45.20%	-59.77%	-72.00%	-54.05%	-39.64%	-26.56%

Neuronetics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	34	40	52	62	49	55	65	71	74
Gross Profit	27	30	40	47	37	43	49	51	54
Operating Income	-9	-13	-19	-26	-22	-27	-35	-30	-34
EBITDA	-8	-12	-19	-26	-21	-26	-31	-22	-34
Interest Expense	1	2	3	3	4	4	4	5	7
Depreciation	-	0	0	1	0	1	1	2	2
Income Before Tax	-11	-16	-24	-29	-27	-31	-37	-30	-43
Income Tax Expense	1	3	0	5	4	4	2	0	0
Net Income	-11	-16	-24	-34	-32	-35	-39	-30	-43
Net Profit Margin	-32.82%	-39.72%	-45.66%	-54.74%	-65.55%	-64.37%	-60.13%	-42.31%	-58.36%

Neuronetics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-9	-5	-7	-9	-13	-12	-12	-10
Operating Cash Flow	-15	-10	2	-12	-4	-5	-8	-16	-3
Investing Cash Flow	5	0	0	0	0	0	-2	0	0
Financing Cash Flow	0	-	22	-	-	-16	9	18	0
Change in Cash	-9	-10	23	-11	-5	-21	-1	1	-3

Neuronetics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-24	-29	-27	-31	-37	-30	-43
Operating Cash Flow	-11	-20	-30	-28	-27	-30	-32	-30
Investing Cash Flow	0	-1	0	0	-9	6	-1	-2
Financing Cash Flow	23	97	2	2	83	0	22	-6
Change in Cash	12	75	-28	-26	45	-23	-10	-40

Global Institutional Holdings in Neuronetics Inc

Funds	Holdings
Vanguard Group Inc	4.15%
BlackRock Inc	3.39%
Balyasny Asset Management LLC	2.28%
Ikarian Capital, LLC	1.66%
Masters Capital Management LLC	1.51%

See all

Insights on Neuronetics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, STIM has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 16.45M → 38.10M (in $), with an average increase of 18.7% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -12.67M → -10.12M (in $), with an average increase of 25.3% per quarter
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 20.9% return, outperforming this stock by 44.4%
NEGATIVE IMPACT
Price Dip
In the last 3 months, STIM stock has moved down by -35.5%

About Neuronetics Inc

with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.

Organisation	Neuronetics Inc
Headquarters	3222 Phoenixville Pike, Malvern, PA, United States, 19355
Industry	Health Technology
CEO	Mr. Keith J. Sullivan
E-voting on shares	Click here to vote

Key Management of Neuronetics Inc

Name	Title
Ms. Sara Grubbs	Senior VP & Chief Revenue Officer
Mr. Stephen J. Furlong M.S.	Senior Advisor to the CEO
Mr. Jeffrey S. Jones	Senior VP & Chief of Operations
Mr. Cory S. Anderson	SVP & Chief Technology Officer
Ms. Lisa Metzner-Rosas	Senior VP & Chief Marketing Officer
Mr. Keith J. Sullivan	President, CEO & Director
Mr. W. Andrew Macan J.D.	EVP, Chief Legal Officer & Corporate Secretary
Mr. Steven E. Pfanstiel C.M.A., M.B.A.	Executive VP, Treasurer & CFO
Mr. William P. Leonard	Chief Clinic Officer

FAQs

What is Neuronetics Inc share price today?

Neuronetics Inc share price today is $2.73 as on November 7, 2025 at 12:37 am IST. Neuronetics Inc share today touched a day high of $2.76 and a low of $2.45.

What is the 52 week high and 52 week low for Neuronetics Inc share?

Neuronetics Inc share touched a 52 week high of $5.92 on March 5, 2025 and a 52 week low of $0.52 on November 12, 2024. Neuronetics Inc stock price today i.e. November 7, 2025 at 12:37 am IST is trending at $2.73,which is 53.89% down from its 52 week high and 425.00% up from its 52 week low.

What is Neuronetics Inc's market capitalisation today?

Neuronetics Inc market capitalisation is $0.00T as on November 7, 2025 at 12:37 am IST.

How to invest in Neuronetics Inc Stock (STIM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neuronetics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neuronetics Inc Shares that will get you 0.5495 shares as per Neuronetics Inc share price of $2.73 per share as on November 7, 2025 at 12:37 am IST.

What is the minimum amount required to buy Neuronetics Inc Stock (STIM) from India?

Indian investors can start investing in Neuronetics Inc (STIM) shares with as little as ₹88.566 or $1 (as of November 7, 2025 at 12:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Neuronetics Inc stock (as per the Rupee-Dollar exchange rate as on November 7, 2025 at 12:37 am IST). Based on Neuronetics Inc share’s latest price of $2.73 as on November 7, 2025 at 12:37 am IST, you will get 3.6630 shares of Neuronetics Inc. Learn more about fractional shares .

What are the returns that Neuronetics Inc has given to Indian investors in the last 5 years?

Neuronetics Inc stock has given -60% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?